focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,748.00
Bid: 1,748.00
Ask: 1,748.50
Change: -27.00 (-1.52%)
Spread: 0.50 (0.029%)
Open: 1,770.00
High: 1,770.00
Low: 1,746.00
Prev. Close: 1,775.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Stocks In Europe Shake Off US Poll Uncertainty

Wed, 04th Nov 2020 12:12

(Alliance News) - Stock prices in Europe were higher on Wednesday afternoon, with markets "remarkably calm" despite the US election still being undecided long after polls in the US have closed.

In London, the FTSE 100 index was up 32.30 points, or 0.6% at 5,819.07 midday Wednesday. The blue-chip index had fallen by 1.0% to a low of 5,731.07 during a frenetic open but soon recovered.

The mid-cap FTSE 250 was up 115.10 points, or 0.7%, at 17,606.80 at midday. The AIM All-Share was up 6.29 points, 0.7%, at 965.67.

The Cboe UK 100 index was up 0.7% at 578.61. The Cboe 250 was up 0.7% at 14,845.61. The Cboe Small Companies grew 0.7% at 9,566.20.

The CAC 40 stock index in Paris was up 0.4%, and Frankfurt's DAX 30 up 0.1%.

"Markets are overall remarkably calm so far today despite maximum election uncertainty," noted AxiCorp analyst Stephen Innes.

"Before the election, many investors would have seen a Biden/Republican Senate as the worst outcome due to small fiscal stimulus combined with higher taxes and more regulation. And yet this scenario looks the most likely now and the market seems OK with that outcome."

President Donald Trump prematurely declared victory and sought Supreme Court intervention to stop vote-counting – even as his Democratic rival Joe Biden voiced confidence in his own chances.

In a divisive election cast under the shadow of the coronavirus pandemic that has claimed more than 230,000 lives in the US, Trump appeared to have avoided a Democratic wave predicted by some polls but he still needs key states to secure another four-year term.

Television networks predicted that Biden would be the first Democrat in 24 years to win Arizona, seizing on the southwestern state's changing demographics and the popularity of astronaut Mark Kelly who was projected to win a Senate seat.

But no other states so far have flipped, and Trump won an early prize in Florida, where his hard line against Latin American leftists helped him make inroads among Cuban Americans.

A New York Times tally has Biden currently leading the way with 227 electoral college votes, compared to Trump's 213, though both are still short of the magic 270 mark with a number of key states yet to declare.

US stock index futures were largely in the green, with just the Dow Jones Industrial Average pointed lower, at 0.2%. The S&P 500 was called 0.3% higher and the Nasdaq Composite by a much-higher 1.9%.

A "blue wave" in favour of the Democrats may have meant tighter regulation for the tech sector, but Republicans looked likely to hold the Senate.

Despite retaining the House of Representatives, the path for Democrats to flip control of the US Senate narrowed sharply, after two key Republicans facing tough reelection battles claimed victory. Democrats flipped two Senate seats in western Colorado and Arizona states on Tuesday, networks projected, but Republicans ousted a vulnerable Democrat in Alabama.

In pre-market trade in New York, Facebook gained 2.5%, Apple was up 2.7%, and Google owner Alphabet was 2.9% higher.

In London, pharmaceutical firms were among the better blue-chip performers.

AstraZeneca climbed 4.9%, Hikma 4.1% and GlaxoSmithKline rose 2.3%. A Democratic president and Senate also might have brought more regulation for the pharmaceutical industry.

Royal Mail topped the FTSE 250s, up 8.8% after JPMorgan raised the UK postal service provider to Overweight from Neutral.

Elsewhere, Marks & Spencer was up 5.2%. The retailer's interim performance was better than expected, despite swinging to a pretax loss of GBP87.6 million from a GBP158.8 million profit.

Revenue for the six months to September declined 16% to GBP4.09 billion from GBP4.86 billion a year before.

Stobart Group shares rose 5.1%. The logistics, energy and aviation firm's pretax loss ballooned to GBP77.4 million from GBP15.5 million though the market took heart from "improving trends" at Stobart Energy, as well as the company's plans to exit Stobart Air.

"The group is seeking to exit that business in early course. To that end, it is engaging actively with parties interested in acquiring its stake and with Aer Lingus to enter a new commercial arrangement beyond December 2022 as part of this process," Stobart explained.

Elsewhere on the main market, construction firm Morgan Sindall rose 5.2%. The company said annual pretax profit will top its GBP50 million to GBP60 million guidance range.

Morgan Sindall declared a 21.0 pence per share interim payout, in line with 2019's interim dividend, having put off a decision on a dividend at the time of its half-year results in August.

Commenting on the upcoming lockdown in England, the company said it does not expect any material disruption.

Construction firms such as Morgan Sindall are able to continue operating during the upcoming English lockdown.

In Westminster, UK members of Parliament are to vote on the new four-week coronavirus restrictions, amid warnings the National Health Service will be overwhelmed with thousands more deaths unless action is taken.

With Labour backing the new restrictions, which are due to come into force on Thursday, the government is expected comfortably to win Wednesday's Commons vote.

Nevertheless, UK Prime Minister Boris Johnson is facing a revolt by some Tory backbenchers angry at the impact on civil liberties and the economic damage the measures will cause.

Ahead of the Commons vote, Johnson warned of "fatalities running in the thousands" if no action was taken as cases across the country continued to rise.

At the same time he sought to offer hope, telling Tuesday's Cabinet meeting that the R number – the reproduction rate of the virus – was "only just above 1" and the new measures would bring it back below that threshold.

Turning to forex, the dollar had a strong start to the European session on Wednesday though its gains have eased as New York prepares to open.

The pound was quoted at USD1.3001 on Wednesday midday, down from USD1.3070 at the London equities close on Tuesday. However, sterling was as low as USD1.2915 earlier in trading.

The euro slipped to USD1.1704, from USD1.1729 late Tuesday.

Versus the yen, the dollar fetched JPY104.60, up from JPY104.50 at the London market close on Tuesday.

The UK services sector grew at a much slower pace in October as the hospitality sector was hit by tighter Covid-19 restrictions, according to final survey data.

IHS Markit/CIPS UK services purchasing managers' index business activity index registered 51.4 points in October, staying above the 50.0 no-change mark but down sharply from 56.1 in September.

The UK composite output index - a weighted average of the services score and Monday's manufacturing PMI - came in at 52.1 in October, the worst reading in four months and down from 56.5 in September.

The eurozone's private sector was treading water in October, as manufacturing growth was offset by a decline in the services industry. The single-currency bloc's services activity index dropped to 46.9 in October, the weakest performance since May and painting a troubled picture for the hospitality industry.

"The eurozone data tells a more worrying story and, given the slight lead compared to the UK in terms of implementing a return of increased Covid measures, we feel this may be a signal of what is to come," analysts at broker Jefferies said.

Still to come on Wednesday, the US services PMI will be released at 1445 GMT. Before that, ADP employment figures are released at 1315 GMT. These are an important precursor to the key October nonfarm payrolls data due Friday.

By Eric Cunha; ericcunha@alliancenews.com;

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.